Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick B Ryan

Showing results (121-130 of 163) with videos related to

Pageof 17
Sort By:
Hypertension (Dallas, Tex. : 1979)|March 29, 2021
Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational StudySeng Chan You, Harlan M Krumholz, Marc A Suchard, et al.
Drug Safety|June 16, 2023
Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety SurveillanceFaaizah Arshad, Martijn J Schuemie, Fan Bu, et al.
BMJ (Clinical Research Ed.)|June 21, 2022
Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort studyXintong Li, Anna Ostropolets, Rupa Makadia, et al.
Journal of the American Medical Informatics Association : JAMIA|December 1, 2020
Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trialsJae Hyun Kim, Casey N Ta, Cong Liu, et al.
Frontiers in Pharmacology|December 13, 2021
Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database AnalysisXintong Li, Lana Yh Lai, Anna Ostropolets, et al.
Drug Safety|July 3, 2014
Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interestRichard D Boyce, Patrick B Ryan, G Niklas Norén, et al.
JAMA|October 27, 2020
Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionSeng Chan You, Yeunsook Rho, Behnood Bikdeli, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2016
Characterizing treatment pathways at scale using the OHDSI networkGeorge Hripcsak, Patrick B Ryan, Jon D Duke, et al.
Plos One|January 17, 2025
CohortDiagnostics: Phenotype evaluation across a network of observational data sources using population-level characterizationGowtham A Rao, Azza Shoaibi, Rupa Makadia, et al.
Studies in Health Technology and Informatics|August 12, 2015
Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational ResearchersGeorge Hripcsak, Jon D Duke, Nigam H Shah, et al.
Pageof 17

Showing results (121-130 of 163) with videos related to

Sort By:
Pageof 17
Hypertension (Dallas, Tex. : 1979)|March 29, 2021
Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational StudySeng Chan You, Harlan M Krumholz, Marc A Suchard, et al.
Drug Safety|June 16, 2023
Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety SurveillanceFaaizah Arshad, Martijn J Schuemie, Fan Bu, et al.
BMJ (Clinical Research Ed.)|June 21, 2022
Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort studyXintong Li, Anna Ostropolets, Rupa Makadia, et al.
Journal of the American Medical Informatics Association : JAMIA|December 1, 2020
Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trialsJae Hyun Kim, Casey N Ta, Cong Liu, et al.
Frontiers in Pharmacology|December 13, 2021
Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database AnalysisXintong Li, Lana Yh Lai, Anna Ostropolets, et al.
Drug Safety|July 3, 2014
Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interestRichard D Boyce, Patrick B Ryan, G Niklas Norén, et al.
JAMA|October 27, 2020
Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionSeng Chan You, Yeunsook Rho, Behnood Bikdeli, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2016
Characterizing treatment pathways at scale using the OHDSI networkGeorge Hripcsak, Patrick B Ryan, Jon D Duke, et al.
Plos One|January 17, 2025
CohortDiagnostics: Phenotype evaluation across a network of observational data sources using population-level characterizationGowtham A Rao, Azza Shoaibi, Rupa Makadia, et al.
Studies in Health Technology and Informatics|August 12, 2015
Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational ResearchersGeorge Hripcsak, Jon D Duke, Nigam H Shah, et al.
Pageof 17